mppf
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2011 (NCT01461083)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 1a (5-HT1a) receptorANTAGONIST
HTR1A antagonist
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- mppf
- mppf
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07013331 | N/A | Sep 1, 2025 | University of Lyon |
| NCT01461083 | Phase 1 | Sep 1, 2011 | Institute for Neurodegenerative Disorders |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute for Neurodegenerative Disorders | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Lyon | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1